The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125439182 12543918 2 F 20160609 20160919 20160711 20160921 EXP DE-ROCHE-1789782 ROCHE 45.00 YR F Y 81.00000 KG 20160921 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125439182 12543918 1 PS Trastuzumab TRASTUZUMAB 1 Subcutaneous MOST RECENT DOSE : 09/JUN/2016 AND 28/JUN/2016 1150353 103792 600 MG SOLUTION FOR INJECTION
125439182 12543918 2 SS EPIRUBICIN EPIRUBICIN 1 Intravenous (not otherwise specified) MOST RECENT DOSE : 17/NOV/2015 0 90 MG/M**2
125439182 12543918 3 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) MOST RECENT DOSE : 17/NOV/2015 0 900 MG/M**2
125439182 12543918 4 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) MOST RECENT DOSE : 25/JAN/2016 AND 26/JAN/2016 0 75 MG/M**2
125439182 12543918 5 SS TAMOXIFEN TAMOXIFEN 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125439182 12543918 1 HER-2 positive breast cancer
125439182 12543918 2 HER-2 positive breast cancer
125439182 12543918 3 HER-2 positive breast cancer
125439182 12543918 4 HER-2 positive breast cancer
125439182 12543918 5 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125439182 12543918 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125439182 12543918 Gait disturbance
125439182 12543918 Headache

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125439182 12543918 1 20160223 0
125439182 12543918 2 20151006 0
125439182 12543918 3 20151006 0
125439182 12543918 4 20151208 0
125439182 12543918 5 20160210 0